DE2056051A1 - Multivalente Vaccine und Verfahren zu ihrer Herstellung - Google Patents

Multivalente Vaccine und Verfahren zu ihrer Herstellung

Info

Publication number
DE2056051A1
DE2056051A1 DE19702056051 DE2056051A DE2056051A1 DE 2056051 A1 DE2056051 A1 DE 2056051A1 DE 19702056051 DE19702056051 DE 19702056051 DE 2056051 A DE2056051 A DE 2056051A DE 2056051 A1 DE2056051 A1 DE 2056051A1
Authority
DE
Germany
Prior art keywords
virus
agents
infectious
infectious agents
parainfluenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702056051
Other languages
German (de)
English (en)
Inventor
Wilhngboro N J Vella. Philip Peter (V St A)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2056051A1 publication Critical patent/DE2056051A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19702056051 1969-11-14 1970-11-13 Multivalente Vaccine und Verfahren zu ihrer Herstellung Pending DE2056051A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87702769A 1969-11-14 1969-11-14

Publications (1)

Publication Number Publication Date
DE2056051A1 true DE2056051A1 (de) 1971-05-27

Family

ID=25369101

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702056051 Pending DE2056051A1 (de) 1969-11-14 1970-11-13 Multivalente Vaccine und Verfahren zu ihrer Herstellung

Country Status (5)

Country Link
AU (1) AU2183370A (enExample)
DE (1) DE2056051A1 (enExample)
FR (1) FR2073358B1 (enExample)
GB (1) GB1270918A (enExample)
NL (1) NL7015493A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2053679A (en) * 1979-07-17 1981-02-11 Gist Brocades Nv Rabies/canine distemper vaccines
US4358438A (en) * 1979-07-17 1982-11-09 Gist-Brocades N.V. Novel polyvalent virus vaccine against rabies and canine distemper
US4657761A (en) * 1985-06-05 1987-04-14 Pinto Cesar M Polyvalent non-specific immuno-stimulating vaccine and method
EP1171158A2 (en) * 1999-04-20 2002-01-16 SmithKline Beecham Biologicals s.a. Vaccine comprising rsv antigen and cpg oligonucleotide
AU2003261375A1 (en) * 2003-08-01 2005-03-07 University Of South Florida Method of treating herpes virus infections

Also Published As

Publication number Publication date
NL7015493A (enExample) 1971-05-18
GB1270918A (en) 1972-04-19
FR2073358A1 (enExample) 1971-10-01
AU2183370A (en) 1972-05-04
FR2073358B1 (enExample) 1974-02-22

Similar Documents

Publication Publication Date Title
DE3911442C2 (de) Impfstoff-Präparation
AT408615B (de) Neue influenzavirus-impfstoffzusammensetzung
AT407958B (de) Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
DE3701066A1 (de) Intravenoes injizierbares immunglobulin mit hohem antikoerpertiter gegenueber dem respiratorischen syncytialvirus, verfahren zu dessen herstellung und pharmazeutische zubereitung, welche dieses enthaelt
DE69420970T2 (de) Impfstoff zubereitungen
DE2423129C2 (de) Temperaturempfindliche, nicht-pathogene Rinder-Adeno-Virus-Mutantenstämme, Verfahren zu ihrer Herstellung und diese Virusstämme enthaltender Lebendimpfstoff
DE3786301T2 (de) Kombinierter Impfstoff.
DE2643641A1 (de) Antigene praeparate und verfahren zu ihrer herstellung
DE2056051A1 (de) Multivalente Vaccine und Verfahren zu ihrer Herstellung
DE2362067C2 (de) Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen
DE2553998C2 (de) Mumpsvaccin und Verfahren zu seiner Herstellung
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE2445819A1 (de) Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen
DE2639012B2 (de) Immuntherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infeklionen
DE3034238A1 (de) Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben
DE1617545C2 (de) Verwendung von informatorischer Ribonucleinsäure als Vaccine
DE3122669A1 (de) "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
DE2415353C2 (enExample)
CH616959A5 (enExample)
Groth et al. STUDIES IN EXPERIMENTAL IMMUNOLOGY OF INFLUENZA VIII. PATHOTOPIC ADJUVANTS.
WO1989005154A1 (fr) Procede pour la preparation d'un virus avirulent pour animaux a sang froid
DE2200376A1 (de) Vaccine gegen Streptococcus equi. und Verfahren zu deren Herstellung
DE2225548C3 (de) Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis
DE2805311A1 (de) Respiratorische synzytial-vakzine
AT216670B (de) Verfahren zur Herstellung einer verbesserten Hundestaupevirusvaccine